Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 627 shares at $11.85 ($7K) on 2022-07-14, disclosed to the SEC on 2022-07-15.
Open-market sale of $7k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |
| OPNT | SELL | 2022-01-12 | $12K | — | Filing → |